1800-272-662
Shopping Cart 0
countryflagAU
Login

Althea Group Holdings Ltd

Healthcare AU AGH

NoneAUD
-(-%)

Last update at 2026-03-06T06:45:04.262324Z

Day Range

--
LowHigh

52 Week Range

0.020.04
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap20.04M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.79400M
  • Revenue TTM15.49M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 7.47M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -4.84300M -32.05700M -13.72500M -12.12400M -15.04600M
Minority interest - - - - -
Net income -8.34700M -32.05700M -13.72500M -12.12400M -15.04600M
Selling general administrative 4.11M 18.14M 16.11M 11.95M 13.11M
Selling and marketing expenses 1.37M 5.95M 4.00M 3.07M 2.47M
Gross profit 7.47M 17.46M 12.62M 9.29M 5.29M
Reconciled depreciation - 2.22M 2.68M 2.75M 2.01M
Ebit -4.11600M -25.06000M -13.12000M -12.06300M -15.04400M
Ebitda -2.40100M -23.47800M -10.43700M -9.31600M -13.03000M
Depreciation and amortization 1.71M 1.58M 2.68M 2.75M 2.01M
Non operating income net other - - - - -
Operating income -2.40100M -8.51300M -13.32400M -12.32100M -14.92900M
Other operating expenses 17.89M 41.10M 13.64M 10.78M 14.84M
Interest expense 0.80M 1.27M 0.60M 0.06M 0.00200M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.73M 0.00800M 0.81M 0.00500M 0.18M
Net interest income - -1.26700M -0.77200M -0.29800M -0.17700M
Extraordinary items -3.50400M -5.98400M - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -19.44800M 1.25M 1.00M 0.53M
Total revenue 15.49M 29.40M 24.82M 20.08M 11.07M
Total operating expenses 9.87M 5.10M 26.21M 22.06M 20.68M
Cost of revenue 8.03M 11.94M 12.20M 10.78M 5.78M
Total other income expense net -2.44200M -23.54400M 0.64M 0.94M 0.53M
Discontinued operations - - - - -
Net income from continuing ops - -32.05700M -13.72500M -12.12400M -15.04600M
Net income applicable to common shares -8.34700M -32.05700M -13.72500M -12.12400M -15.04600M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 20.49M 23.65M 48.34M 56.56M 53.91M
Intangible assets 0.00800M - 0.90M 1.58M 2.20M
Earning assets - - - - -
Other current assets 1.01M 1.71M 1.51M 1.45M 0.60M
Total liab 21.06M 23.34M 18.57M 15.12M 11.22M
Total stockholder equity -0.57400M 0.31M 29.77M 41.45M 42.70M
Deferred long term liab - - - - -
Other current liab 0.63M 2.48M 1.68M 0.64M 0.76M
Common stock 93.97M 86.33M 85.34M 82.04M 68.05M
Capital stock - - 85.34M 82.04M 68.05M
Retained earnings -94.29900M -88.74400M -56.75100M -43.47700M -40.12000M
Other liab - - 0.86M 0.34M 0.46M
Good will - - 17.74M 17.74M 17.74M
Other assets - - 0.42M 0.33M 0.35M
Cash 0.53M 0.33M 3.87M 6.21M 6.39M
Cash and equivalents - - - - -
Total current liabilities 14.97M 16.90M 16.92M 9.77M 6.76M
Current deferred revenue - 1.66M 3.68M 3.59M 2.72M
Net debt 4.66M 6.21M 0.98M -1.06800M -2.33900M
Short term debt 0.59M 1.30M 4.07M 0.14M 0.05M
Short long term debt - - 3.88M - -
Short long term debt total 5.19M 6.54M 4.85M 5.14M 4.05M
Other stockholder equity - - -28.58900M -38.56700M -27.92600M
Property plant equipment - - 13.57M 19.15M 18.74M
Total current assets 10.30M 10.89M 15.72M 17.78M 14.88M
Long term investments - - 0.42M 0.33M 0.35M
Net tangible assets - - 11.13M 22.14M 22.76M
Short term investments - - - - -
Net receivables 6.63M 4.86M 4.13M 6.30M 2.68M
Long term debt - - - - -
Inventory 2.13M 3.98M 6.20M 3.82M 5.21M
Accounts payable 13.75M 11.46M 7.50M 5.41M 3.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.24400M 2.73M 1.18M 2.88M 14.77M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.08M 1.22M -32.20700M -38.46300M -38.67900M
Deferred long term asset charges - - - - -
Non current assets total 10.19M 12.76M 32.62M 38.79M 39.03M
Capital lease obligations - - 0.97M 5.14M 4.05M
Long term debt total - - 0.79M 5.00M 4.00M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - 2.29M -1.48700M -0.98200M -2.40300M
Change to liabilities - - 3.70M 2.90M 3.15M
Total cashflows from investing activities 0.98M 2.29M -1.48700M -0.98200M -2.40300M
Net borrowings - -1.24500M 3.69M -0.16400M -0.02300M
Total cash from financing activities 6.31M -1.43900M 5.55M 9.89M 9.18M
Change to operating activities - - -0.02000M -0.92700M 1.38M
Net income -8.34700M -32.05700M -13.72500M -12.12400M -15.04600M
Change in cash 0.20M -3.54300M -2.33100M -0.18300M -3.75500M
Begin period cash flow 0.33M 3.87M 6.21M 6.39M 10.14M
End period cash flow 0.53M 0.33M 3.87M 6.21M 6.39M
Total cash from operating activities -7.09400M -4.39500M -6.29400M -9.05400M -10.44500M
Issuance of capital stock - 0.12M 1.95M 10.04M 9.27M
Depreciation 1.72M 2.22M 2.06M 2.09M 1.42M
Other cashflows from investing activities 1.90M 2.73M - - 0.00000M
Dividends paid - - - 0.00600M 0.01M
Change to inventory 1.85M 2.22M -2.38200M 1.39M -2.98200M
Change to account receivables -1.76700M -0.73500M 2.18M -3.62200M -1.29500M
Sale purchase of stock 3.83M 0.12M 1.95M -0.01300M -0.01300M
Other cashflows from financing activities -0.71400M -0.31800M 3.69M -0.11200M -0.02300M
Change to netincome - - 1.28M 0.58M 2.33M
Capital expenditures 0.92M 0.44M 1.49M 0.98M 2.40M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.79300M 4.38M -0.20600M -2.22800M -4.27700M
Stock based compensation - - 1.16M 1.01M 2.52M
Other non cash items 0.33M 21.06M 5.37M 0.98M 3.18M
Free cash flow -8.01400M -4.83100M -7.78100M -10.03600M -12.84800M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AGH
Althea Group Holdings Ltd		 - -% - - - 1.29 0.53 1.49 -1.8035
AFP
Aft Pharmaceuticals Ltd		 - -% 3.00 23.08 19.88 1.35 3.81 1.72 13.67
VLS
Vita Life Sciences Ltd		 -0.02 0.80% 2.48 13.89 42.73 1.46 2.42 1.24 6.53
SNT
Syntara Ltd		 -0.001 3.33% 0.03 - 20.45 6.32 4.62 6.32 -2.1607
MVP
Medical Developments International Ltd		 0.005 1.23% 0.41 - 166.67 1.14 0.83 0.75 11.48

Reports Covered

Stock Research & News

View All

Profile

Peak Processing Limited, together with its subsidiaries, manufactures, distributes, and sells recreational cannabis products in Canada and the United States. The company offers cannabis products, including beverages, hydrocarbon extracts, oils, vapes, oils, topicals, powders, infused flowers, and edibles. It also provides market insights and analysis, product development, manufacturing, commercialization, distribution, and product rework services. The company sells its products through retail stores. The company was formerly known as Althea Group Holdings Limited and change its name to Peak Processing Limited in November 2025. Peak Processing Limited was founded in 2016 and is based in Melbourne, Australia.

Althea Group Holdings Ltd

180 Lonsdale Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Joshua Michael Fegan CEO, MD & Exec. Director NA
Mr. Robert Meissner CFO & Company Sec. NA
Mr. David Sauer Gen. Counsel NA
Mr. Joshua Michael Fegan CEO, MD & Executive Director NA
Mr. Robert Meissner CFO & Company Secretary NA
Mr. David Sauer General Counsel NA
Mr. Joshua Michael Fegan CEO, MD & Executive Director NA
Mr. Robert Meissner CFO & Company Secretary NA
Mr. David Sauer General Counsel NA
Mr. Joshua Michael Fegan CEO, MD & Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.